Concepedia

Publication | Open Access

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer

DOIFull Paper Access

38

Citations

67

References

2020

Year

Goldie Y.L. Lui, Reid Shaw, Franz X. Schaub, Isabella N. Stork, Kay E. Gurley, Caroline Bridgwater, Robert L. Diaz, Rachele Rosati, Hallie A. Swan, Tan A. Ince,
EBioMedicine

References

YearCitations

Page 1